José Antonio García Erce: Which Oral Iron Therapy Should We Choose?
José Antonio García Erce, Vocal-elect of the Board of the Spanish Society of Hematology and Hemotherapy, shared a post on LinkedIn about recent article he and his colleagues co-authored, published in Journal of Clinical Medicine, adding:
“We are honoured to have published this review with Drs. Santiago García Lopez and Antonio Martínez-Francés in a special issue of Journal of Clinical Medicine (JCM) MDPI: Special Issue Clinical Updates in Transfusion Medicine and Patient Blood Management) open to receive more papers.
Our thanks to Dr Salvador Payán-Pernía for his thorough professional critique which has been instrumental in improving this work”
Title: Iron Deficiency and Oral Treatments: Limitations, Pharmacokinetics, and the Role of Iron Protein Succinylate in Clinical Practice
Authors: José Antonio García-Erce, Santiago García-López, Antonio Martínez-Francés
Other posts featuring José Antonio García Erce on Hemostasis Today.
-
Aug 3, 2026, 12:44Replaying the CSL Symposium on Gene Therapy Durability in Haemophilia – EAHAD
-
Aug 3, 2026, 12:43Shinta C: Takeda Marks a Milestone in Hemophilia Care
-
Aug 3, 2026, 12:37Deepak Kumar Dasmohapatra: Honored for Contributions to Transfusion Medicine and Immunohematology by the Governor of Chhattisgarh
-
Aug 3, 2026, 12:30Furkan Bahar: Thrombotic and Hemorrhagic Risk Profiles in Advanced Melanoma – Targeted vs Immune Combination Therapies
-
Aug 3, 2026, 12:28Tayyaba Iftikhar: When Platelets Talk to Cancer Cells
-
Aug 3, 2026, 12:19Heparin Beyond Anticoagulation in Sepsis – JTH
-
Aug 3, 2026, 12:14Yaqui Valenzuela: Hemophilia Care Evolves Beyond Factor Replacement
-
Aug 3, 2026, 11:59Flora Peyvandi: Roctavian Withdrawal Signals Adoption Challenges
-
Aug 3, 2026, 11:49Thirunavukkarasu Angappan: Gene Therapy’s Slow Road to Routine Hemophilia Care